Typically self-limiting
those with diabetes or obesity but no medication (300,000 patients in the study) Those on GLP-1 meds were 66% more likely to have gastroparesis 0.53% of patients had paralysis that is the equivalent of 1 in every 200 people on semaglutide or tirzepatide They were more likely to have nausea, vomition, or reflux and be prescribed a proton pump inhibitor They were more likely to have drug-induced pancreatitis and need gallbladder removal
Cover until ready to serve
1-6 Acute heavy metal intoxications may damage central nervous function, the cardiovascular and gastrointestinal systems, lungs, kidneys, liver, endocrine glands, and bones
Sometimes, a man may not know he has any obstruction until he suddenly finds himself unable to urinate at all
Mosaic evolution of the insulin-like growth factors